IDXX Stock IDEXX Laboratories, Inc.
US · NasdaqGSLast in our picks 2026-10-02 — not in the current list; analysis below is from that screen
Veterinary diagnostics leader with resilient recurring revenue and premium growth visibility.
Future value: $701.33 (+35.46%) · 6-12 months · analyst consensus
Signal breakdown
- ▸High-quality recurring model and durable momentum.
- ▾Below 50-day MA (-4.86%)
- ▾Near 52-week low (6.4% of range)
- ▸~35% upside to price target
Is IDXX a buy right now?
Trend: IDXX is trading above the 50-day average (+6.90%), RSI 44 — neutral momentum, with a 3-month return of +0.12%.
Valuation & quality: IDEXX Laboratories, Inc. trades on a trailing P/E of 40.1, forward P/E 34.0, PEG 3.07, price-to-book 27.89; fundamentals show net margin 25.0%, return on equity 74.2%, revenue growth 9.7% year on year.
Analyst consensus: 12 analysts have a mean 12-month price target of $698.00 (+22.4% vs the last close; range $470.00 – $805.00), consensus rating “buy”.
Our screen: BUY (score 2) — Veterinary diagnostics leader with resilient recurring revenue and premium growth visibility.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -14.40% | -0.20% | +0.50% | -6.60% | +6.20% | -0.40% | -6.20% | +9.20% |
Fundamentals
Analyst price target
Technical signals
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Sector: Healthcare · Industry: Diagnostics & Research · United States · 11,000 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.